In Heart attack Uroken 500000IU Injection helps lower your blood pressure and make it easier for your heart to pump blood around your body. This reduces the chances of you having a heart attack. It can also reduce the risk of dying if it is given immediately after a heart attack. It is given as an injection by a doctor or nurse and should not be self-administered. In Pulmonary embolism Pulmonary embolism refers to clotting of blood in your lungs. Uroken 500000IU Injection prevents this clot formation in your lungs. This helps the blood flow freely around your body thereby preventing a heart attack or stroke. It prevents the formation of blood clots and also prevents the existing ones from growing bigger in size. Make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine. Follow your doctor’s instructions carefully to get maximum benefit.
It is not known whether it is safe to consume alcohol with Uroken 500000IU Injection. Please consult your doctor.
Uroken 500000IU Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Uroken 500000IU Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Not relevant, as Uroken 500000IU Injection is intended for use in hospitalised patients.
Uroken 500000IU Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Uroken 500000IU Injection may not be needed in these patients. Please consult your doctor. Use of Uroken 500000IU Injection is not recommended in patients with severe kidney disease.
Uroken 500000IU Injection should be used with caution in patients with liver disease. Dose adjustment of Uroken 500000IU Injection may be needed. Please consult your doctor.
If you miss a dose of Uroken 500000IU Injection, please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Life Medicare & Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vhb Life Sciences Inc || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Biosena Lifescience || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: TTK Healthcare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Bharat Serums & Vaccines Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Chandra Bhagat Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: United Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)